Udo Ehrenfeld
 | The topic of this article may not meet Wikitia's general notability guideline. |
Udo Ehrenfeld | |
|---|---|
| Add a Photo | |
| Born | June 4, 1942 Tübingen, Germany |
| Died | April 13, 2001 Recife, Brazil |
| Nationality | German |
| Alma mater | Immunologist |
Kurt-Udo Ehrenfeld (born June 4, 1942) was a German immunologist who created a novel cancer imagine technique and therapeutic that was derived from a cell wall extract of the bacteria Nocardia opaca.
Biography
He was born in Tübingen, Germany in 1942. He died in Recife, Brazil 13 April 2001. He founded Jomol Pharma GmbH in Regensburg, Germany on the 29th July 1985.[1]
He had worked at the renowned Max Planck institute around 1974 and developed the "German Ehrenfeld" program as it was called at the time.[2]
A book entitled written "Ich lebe noch!" in 1996 telling the story of individuals who had improved with his novel cancer therapeutic agent.
References
- ↑ "JOMOL Pharma GmbH, Regensburg". www.northdata.de (in Deutsch). Retrieved 2023-07-07.
- ↑ "JOMOL Pharma GmbH, Regensburg" (PDF). www.northdata.de (in Deutsch). Retrieved 2023-07-07.
External links
This article "Udo Ehrenfeld" is from Wikipedia. The list of its authors can be seen in its historical. Articles taken from Draft Namespace on Wikipedia could be accessed on Wikipedia's Draft Namespace.